Jump to content Jump to main menu Jump to sub menu

Latest News

10 July 2015 - Multi-national asthma study award

QED announces the award of a multi-national asthma study for a European biotech company.The study which will be conducted in 5 countries is set out to recruit 200 patients. Chief Executive Thomas Ogorka comments:

16 February 2015 - Our rare disease division orphan reach is sponsoring the WODC 2015

orphan reach

orphan reach

QED’s rare disease division orphan reach is sponsoring the World Orphan Drug Congress 2015 in Washington D.C. from 22-24 April. Feel free to visit us at stand #6

23 May 2013 - Healthcare at Home joins QED in OrphanReach alliance

Healthcare at Home Ltd, Europe’s leading provider of home-based healthcare and patient support company has joined QED Clinical Services Ltd, a global full service clinical research organization (CRO), as part of the strategic alliance, OrphanReach.
Read more »

26 July 2013 - Colpitts joins OrphanReach Alliance

Corporate travel logistics specialists Colpitts World Travel has been named as a partner to the OrphanReach Alliance, set up to service the growing demand in delivering global drug trials within the pharmaceutical sector. 

Read more »

15 March 2013 - Reaching out to Rare Disorders

Yesterday, QED met with Helen Carter to hear about her daughter Hollie, who suffers from Niemann Pick Type C. QED are proud to support this cause.  There is Hope for Hollie

Read more »